Immunology of Infectious Disease News Volume 9.02 | Jan 20 2021

    0
    39






    IIDN 9.02 | Jan 20 2021


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 9.02 – 20 January, 2021
    TOP STORY

    Local Immune Response to Food Antigens Drives Meal-Induced Abdominal Pain

    Scientists showed that a bacterial infection and bacterial toxins could trigger an immune response that leads to the production of dietary-antigen-specific IgE antibodies in mice, which were limited to the intestine.
    [Nature]

    Abstract

    Request a copy of the COVID-19 wallchart.
    PUBLICATIONSRanked by the impact factor of the journal
    SARS-CoV-2

    Evolution of Antibody Immunity to SARS-CoV-2

    Investigators report on the humoral memory response in a cohort of 87 individuals assessed at 1.3 and 6.2 months after infection. They found that IgM, and IgG anti-SARS-CoV-2 spike protein receptor binding domain antibody titres decreased significantly with IgA being less affected.
    [Nature]

    Full Article

    A
    Therapeutic Neutralizing Antibody Targeting Receptor Binding Domain of SARS-CoV-2 Spike Protein

    Researchers screened human monoclonal antibodies targeting the receptor binding domain of the viral spike protein via antibody library constructed from peripheral blood mononuclear cells of a convalescent patient.
    [Nature Communications]

    Full Article

    MDA5
    Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells

    Scientists found that SARS-CoV-2 replication induced a delayed interferon response in lung epithelial cells. By screening 16 putative sensors involved in sensing of RNA virus infection, they found that MDA5 and LGP2 primarily regulated IFN induction in response to SARS-CoV-2 infection.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Cytoplasmic
    Short Linear Motifs in ACE2 and Integrin β3 Link SARS-CoV-2 Host Cell Receptors to Mediators of Endocytosis and Autophagy

    The authors measured the binding affinity of predicted interactions between short linear motifs in the cytoplasmic tails of angiotensin-converting enzyme 2 and integrin β3 with proteins that mediated endocytic trafficking and autophagy.
    [Science Signaling]

    Full Article

    Epitope-Resolved
    Profiling of the SARS-CoV-2 Antibody Response Identifies Cross-Reactivity with Endemic Human Coronaviruses

    Researchers studied cross-reactivity using a highly multiplexed peptide assay to generate an epitope-resolved view of IgG reactivity across all human coronaviruses in both COVID-19 convalescent and negative donors.
    [Cell Reports Medicine]

    Full Article

    MORE IMMUNOLOGY OF INFECTIOUS DISEASE

    Infection
    Trains the Host for Microbiota-Enhanced Resistance to Pathogens

    Scientists showed that gut microbiota from previously infected hosts display enhanced resistance to infection. This long-term functional remodeling was associated with altered bile acid metabolism leading to the expansion of taxa that utilized the sulfonic acid taurine.
    [Cell]

    AbstractGraphical Abstract

    Vaccination
    Induces Maturation in a Mouse Model of Diverse Unmutated VRC01-Class Precursors to HIV-Neutralizing Antibodies with >50% Breadth

    Using sequential immunization of immunoglobulin-humanized mice expressing diverse unmutated VRC01-class antibody precursors, investigators elicited serum responses capable of neutralizing viruses bearing glycan276 and isolated multiple lineages of VRC01-class bnAbs.
    [Immunity]

    AbstractGraphical Abstract

    A
    Class of Viral Inducer of Degradation of the Necroptosis Adaptor RIPK3 Regulates Virus-Induced Inflammation

    Using a targeted small interfering RNA screen, scientists identified a viral inhibitor found in cowpox virus and other orthopoxviruses that bound to the host SKP1-Cullin1-F-box machinery and the essential necroptosis kinase receptor interacting protein kinase 3.
    [Immunity]

    AbstractGraphical Abstract

    Heightened
    Resistance To Host Type 1 Interferons Characterizes HIV-1 at Transmission and after Antiretroviral Therapy Interruption

    Researchers characterized the IFN-I sensitivity of 500 clonally derived HIV-1 isolates from the plasma and CD4+ T cells of 26 individuals sampled longitudinally after transmission or after antiretroviral therapy and analytical treatment interruption.
    [Science Translational Medicine]

    Full Article

    Listeria monocytogenes
    Upregulates Mitochondrial Calcium Signaling To Inhibit LC3-Associated Phagocytosis as a Survival Strategy

    Invasion of macrophages by L. monocytogenes induced mitochondrial Ca2+ (mtCa2+) uptake through the mtCa2+ uniporter, which in turn increased acetyl-coenzyme A production by pyruvate dehydrogenase.
    [Nature Microbiology]

    Abstract

    Lipophagy
    Confers a Key Metabolic Advantage That Ensures Protective CD8A T-Cell Responses against HIV-1

    The authors showed that, after both polyclonal and HIV-1-specific activation, CD8A T-cells from antiretroviral treatments displayed reduced autophagy-dependent degradation of lysosomal contents when compared to naturally HIV-1 protected elite controllers.
    [Autophagy]

    Abstract

    Generation
    of HIV-Resistant Cells with a Single-Domain Antibody: Implications for HIV-1 Gene Therapy

    GPI-anchored m36.4, a single-domain antibody targeting the coreceptor-binding site of gp120, was constructed with a lentiviral vector. Scientists verified that m36.4 was efficiently expressed on the plasma membrane of transduced TZM-bl cells and targeted lipid raft sites without affecting the expression of HIV receptors
    [Cellular & Molecular Immunology]

    Full Article

    Critical
    Role of Syk-Dependent STAT1 Activation in Innate Antiviral Immunity

    Researchers identified that STAT1 activation is independent of cytokines and JAKs at the early infection stage of some viruses, including influenza A virus.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Who does immunology research in the Bolivian Andes? He does. Read Jason Young's story.
    REVIEWS

    The Renaissance of Chemically Generated Bispecific Antibodies

    Investigators review chemical methods for the generation of bispecific antibodies, showing that the newest examples of these techniques are worthy competitors to the industry-standard expression-based strategies.
    [Nature Reviews Chemistry]

    Abstract

    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection

    Scientists summarize existing data on the replication of SARS-CoV-2 in different tissues in both patients and ex vivo models.
    [Clinical Microbiology Reviews]

    Full Article

    The Microbiota in Pneumonia: From Protection to Predisposition

    The authors discuss how the healthy microbiota protects against pneumonia and how host factors and medical interventions alter the microbiota, thus influencing susceptibility to pneumonia.
    [Science Translational Medicine]

    Full Article

    INDUSTRY AND POLICY NEWS

    Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase III Helicobacter pylori (H. pylori) Trial

    Phathom Pharmaceuticals, Inc. announced that it has completed patient enrollment in PHALCON-HP, a pivotal Phase III clinical trial of vonoprazan in combination with amoxicillin and vonoprazan in combination with amoxicillin and clarithromycin for the eradication of H. pylori infection.
    [Phathom Pharmaceuticals, Inc. (Globe Newswire, Inc.)]

    Press Release

    US FDA Accepts for Priority Review the Biologics License Application for V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine, for Use in Adults 18 Years of Age and Older

    Merck announced the FDA accepted for priority review a Biologics License Application for V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in adults 18 years of age and older.
    [Merck (BusinessWire, Inc)]

    Press Release

    AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development

    AvantGen, Inc. announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development.
    [AvantGen, Inc. (BusinessWire, Inc)]

    Press Release

    FEATURED EVENT

    AACR: COVID-19 and Cancer

    February 3 – 5, 2021
    Virtual


    > See All Events

    JOB OPPORTUNITIES


    Scientist/Project Leader – COVID-19 Target and Drug Discovery

    University of Strasbourg – Strasbourg, France

    Postdoctoral
    Fellow – Human Immunology and COVID-19

    University of Gothenburg – Gothenburg, Sweden


    Postdoctoral Fellow – T Cell Immunology and Transplantation

    Stanford School of Medicine – Stanford, California, United States

    Lab Coordinator – Breast Cancer Immunology

    Salk Institute of Biological Studies – La Jolla, California, United States


    Postdoctoral Researcher – Single-Cell Immunology

    Karolinska Institutet – Huddinge, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Immunology of Infectious Disease News
    Archives Contact Us
    Immunology of Infectious Disease News Twitter